Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
Theratechnologies announced it will release its third quarter financial results for fiscal 2022, ending on August 31, on October 13, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies announced it will release its third quarter financial results for fiscal 2022, ending on August 31, on October 13, 2022. A conference call will take place at 8:30 AM ET to discuss these results and other business updates, featuring CEO Paul Lévesque and other management team members.
Participants should dial in at least ten minutes early. The call can also be accessed via webcast.
Positive
- Upcoming conference call to discuss Q3 financial results indicates ongoing transparency with investors.
Negative
- None.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +8.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its third quarter of fiscal 2022 ended August 31, on Thursday, October 13, 2022.
The conference call will be held at 8:30 a.m. (ET) on October 13, 2022 to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Philippe Dubuc and Chief Medical Officer Christian Marsolais, who will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access.
Conference call dial-in and replay information is below:
| CONFERENCE CALL INFORMATION | |
| Conference Call Date: | October 13, 2022 |
| Conference Call Time: | 8:30 AM ET |
| North America Dial-in: | 1- 877-513-4119 |
| International Dial-in: | 1- 412-902-6615 |
| Access Code: | 0675980 |
| CONFERENCE CALL REPLAY | |
| North America Dial-in: | 1- 877-344-7529 |
| International Dial-in: | 1- 412-317-0088 |
| Replay Access Code: | 1261932 |
| Replay End Date | October 20, 2022 |
The live conference call will be accessible via webcast at: https://edge.media-server.com/mmc/p/69eduxxu
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
Investors:
Elif McDonald
Senior Director, Investor Relations
1-438-315-8563
ir@theratech.com
Media Contact:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.